Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Cyclooxygenase-2 expression rises in ductal carcinoma in situ
June 16th, 2005
Cyclooxygenase-2 expression rises in ductal carcinoma in situ. According to a study from Italy, "there is considerable evidence that links cyclooxygenase 2 (COX-2) to the development of cancer. The aim of our study was to assess, by immunohistochemistry, COX-2 expression in ductal carcinoma in situ (DCIS) and its possible correlation with HER-2/neu, vascular endothelial growth factor (VEGF) expression and other common immunohistochemical parameters (p53, ER, PGR, Ki67)." "Tissue samples of 49 archival cases of DCIS without any invasive component were analyzed for COX-2, HER-2/neu, VEGF, estrogen and progesterone receptors, Ki67 and p53 by...
Source: Women's Health Weekly (2005-06-16)
|
